ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.66503
-0.14%
Brent Oil
82.845
1.06%
Bitcoin
70,031.11
2.22%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Eurand N.V. (MM) (EURX)

  7. Eurand N.V. (MM) (EURX) Noticias

EURX

Eurand N.V. (MM) (EURX)

Eurand N.V. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EURX
FechaHoraFuenteTítuloSímboloCompañía
01/03/201115:21Edgar (US Regulatory)(25-NSE)NASDAQ:EURXEurand N.V. (MM)
28/02/201114:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:EURXEurand N.V. (MM)
28/02/201113:58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:EURXEurand N.V. (MM)
28/02/201113:46Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:EURXEurand N.V. (MM)
14/02/201112:49Edgar (US Regulatory)Schedule 13GNASDAQ:EURXEurand N.V. (MM)
09/02/201113:22Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:EURXEurand N.V. (MM)
31/01/201115:20MarketwiredEurand and Axcan Announce Extension of the Tender OfferNASDAQ:EURXEurand N.V. (MM)
19/01/201115:08MarketwiredEurand and Axcan Announce Shareholder Approval of Certain Matters Relating to the Tender Offer and Approval From All Relevant AnNASDAQ:EURXEurand N.V. (MM)
12/01/201106:00MarketwiredEurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CISNASDAQ:EURXEurand N.V. (MM)
22/12/201016:24Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:EURXEurand N.V. (MM)
21/12/201015:21Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:EURXEurand N.V. (MM)
20/12/201005:06Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:EURXEurand N.V. (MM)
01/12/201016:28Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:EURXEurand N.V. (MM)
01/12/201012:36Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:EURXEurand N.V. (MM)
01/12/201007:00MarketwiredEurand to Be Acquired by Axcan for $12.00 per Share in CashNASDAQ:EURXEurand N.V. (MM)
05/11/201005:55MarketwiredEurand Reports Recent Highlights and Financial Results for Third Quarter 2010NASDAQ:EURXEurand N.V. (MM)
01/11/201015:07MarketwiredEurand to Participate in Upcoming Investor ConferencesNASDAQ:EURXEurand N.V. (MM)
21/10/201008:00MarketwiredEurand Announces Conference Call on Third Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
21/10/201006:00MarketwiredEurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors or H2 Receptor Antagonists in Patients With CF and Pancreatic INASDAQ:EURXEurand N.V. (MM)
24/09/201008:00MarketwiredEurand to Present at Jefferies 2010 Global SpecPharma and European Healthcare ConferenceNASDAQ:EURXEurand N.V. (MM)
10/09/201006:00MarketwiredEurand Chief Financial Officer to Step Down in Early 2011NASDAQ:EURXEurand N.V. (MM)
06/08/201014:59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:EURXEurand N.V. (MM)
06/08/201006:00MarketwiredEurand Reports Recent Highlights and Second Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
29/07/201007:30MarketwiredEurand to Present at Bank of America Merrill Lynch Specialty Pharmaceuticals ConferenceNASDAQ:EURXEurand N.V. (MM)
19/07/201008:28MarketwiredEurand Announces Conference Call on Second Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
17/06/201006:00MarketwiredEurand Announces Data on Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs to FDA-ANASDAQ:EURXEurand N.V. (MM)
16/06/201006:00MarketwiredEurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals BusinessNASDAQ:EURXEurand N.V. (MM)
14/05/201018:05GlobeNewswire Inc.Semi-Annual Changes to the NASDAQ Biotechnology IndexNASDAQ:EURXEurand N.V. (MM)
14/05/201006:00MarketwiredEurand Reports Recent Highlights and First Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
03/05/201006:00MarketwiredEurand Announces National Title Sponsorship of New Cystic Fibrosis Foundation FundraiserNASDAQ:EURXEurand N.V. (MM)
 Showing the most relevant articles for your search:NASDAQ:EURX

Su Consulta Reciente

BOV
HBSA3
Hidrovias DO Brasil ON
NASDAQ
ICVX
Icosavax
NYSE
VGAC
VG Acquisition
AMEX
UEUR
ETNs link to Velocitysha...
LSE
65DS
Akademiska 26
COIN
GREEDCGBP
NYSE
ALVU
Allvue Systems
NASDAQ
TRCH
Torchlight Energy Resour...
BIT
P19KH7
BNP Paribas Issuance
NASDAQ
BWMCW
Boxwood Merger
LSE
HEMA
Hsbc Msci Em Ac
KOSPI
053690
Hanmi Global
LSE
93FD
Utd Utl Wt F 31
NYSE
PCPC.WS
Periphas Capital Partner...
TSXV
FB.H
BIT
F15911
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados